Clinical trials
Completed trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,710 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 17 |
| 2001 | 37 |
| 2002 | 43 |
| 2003 | 68 |
| 2004 | 98 |
| 2005 | 100 |
| 2006 | 134 |
| 2007 | 126 |
| 2008 | 150 |
| 2009 | 170 |
| 2010 | 142 |
| 2011 | 159 |
| 2012 | 138 |
| 2013 | 151 |
| 2014 | 135 |
| 2015 | 146 |
| 2016 | 132 |
| 2017 | 138 |
| 2018 | 140 |
| 2019 | 96 |
| 2020 | 92 |
| 2021 | 81 |
| 2022 | 71 |
| 2023 | 60 |
| 2024 | 20 |
| 2025 | 10 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,710 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Helsinki University Central Hospital | 144 |
| Turku University Hospital | 109 |
| GlaxoSmithKline | 106 |
| Boehringer Ingelheim | 92 |
| Novartis Pharmaceuticals | 91 |
| Tampere University Hospital | 89 |
| Sanofi | 86 |
| Hoffmann-La Roche | 83 |
| Pfizer | 82 |
| AstraZeneca | 75 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 118 |
| Diabetes Mellitus | 77 |
| Prostatic Neoplasms | 61 |
| Obesity | 52 |
| Atrial Fibrillation | 44 |
| Pulmonary Disease, Chronic Obstructive | 44 |
| Arthritis, Rheumatoid | 43 |
| Breast Neoplasms | 43 |
| Diabetes Mellitus, Type 1 | 43 |
| Major Depressive Disorder | 41 |
Trials
Showing 1 to 25 of 2,710. Each trial links to its page on Pharma Observatory.
2,610 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.